[Pregnancy in adolescence]. / Schwangerschaft bei Jugendlichen.

The retrospective study compares the pregnancy, labour, lying-in period and the newborn of adolescents with corresponding data for a group of mothers aged 21 to 30. Both groups were the same size. Menarche had been 6-7 months earlier on average for the pregnant adolescents. Pregnancy was complicated in the teenage group by a markedly higher incidence of gestosis, greater frequency of pregnancy anaemia, and a tendency to deliver prematurely. Medical care during pregnancy was found to have been much more inadequate for this group. With onset of labour more often spontaneous, shorter labour, and the rate of spontaneous delivery increased, labour and delivery could be rated as free from complications and low-risk. There was no evidence that morbidity during the lying-in period was greater for the juveniles. The newborn was found to be at greater risk in the adolescent group, with perinatal mortality predominantly linked to the incidence of premature births.

[The induction of abortion in the second trimester by combined administration of minprostin and sulproston, compared with the use of sulproston alone (author's transl)]. / Kombinierter Einsatz von Minprostin und Sulproston bei der Aborteinleitung im II. Trimenon und bei der Geburtseinleitung beim toten Kind im Vergleich zum alleinigen Sulproston-einsatz.

Sulproston was used to terminate 125 pregnancies from 13 to 41 weeks duration, between 1.1.1979 and 31.12.1980. The indications for termination of pregnancy included medical problems, genetic disorders and neural tube defects. Sulproston alone was used in 30 cases. In the remaining 95 cases the cervix uteri was treated with Minprostin F2a before Sulproston application. The failure rate was 20% when Sulproston alone was used at varying dosage. There were no failures using the combination therapy. Combined therapy reduced the time necessary for abortion by an average of four hours, the period of painful contractions was reduced, and less Sulproston was needed. The incidence of side effects was comparable in the two groups. There were no complications from the intracervical application of Minprostin F2a.

PIP: Sulproston was used to terminate 125 pregnancies from 13-41 weeks duration between January 1, 1979-December 31, 1980. The indications for termination of pregnancy included medical problems, genetic disorders, and neural tube defects. Sulproston alone was used in 30 cases, and the remaining 95 cases, the cervix uteri was treated with Minprostin F2alpha before Sulproston application. The failure rate was 20% when Sulproston alone was used at varying doses. There were no failures using the combination therapy. Combined therapy reduced the time necessary for abortion by an average of 4 hours, the period of painful contractions was reduced, and less Sulproston was needed. The incidence of side effects was comparable in the 2 groups. There were no complications from the intracervical application of Minprostin F2alpha. (author's)